Published in Mol Carcinog on June 02, 2017
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
On the origin of cancer cells. Science (1956) 49.55
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
How mitochondria produce reactive oxygen species. Biochem J (2009) 13.03
Mitochondrial formation of reactive oxygen species. J Physiol (2003) 10.73
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov (2009) 10.32
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
Cancer's molecular sweet tooth and the Warburg effect. Cancer Res (2006) 7.24
Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21
Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res (1991) 6.99
Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci (2010) 6.30
Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem (2008) 5.94
Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis (2000) 5.78
ROS stress in cancer cells and therapeutic implications. Drug Resist Updat (2004) 5.20
Physiological roles of mitochondrial reactive oxygen species. Mol Cell (2012) 5.05
Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell (2006) 3.97
Purification of the o-dianisidine peroxidase from Escherichia coli B. Physicochemical characterization and analysis of its dual catalatic and peroxidatic activities. J Biol Chem (1979) 3.90
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics (2003) 3.84
Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol (2006) 3.67
Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog (2006) 3.65
ROS function in redox signaling and oxidative stress. Curr Biol (2014) 3.35
Reactive oxygen species in cancer. Free Radic Res (2010) 3.20
Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep (2008) 2.90
Cellular fatty acid metabolism and cancer. Cell Metab (2013) 2.82
Membrane transport of hydrogen peroxide. Biochim Biophys Acta (2006) 2.81
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest (2009) 2.80
Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev (2014) 2.66
Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer (2013) 2.59
UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J (2011) 2.36
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest (2003) 2.35
Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem (1998) 2.28
Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther (2008) 2.07
Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med (2011) 1.91
p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res (2005) 1.88
Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett (2006) 1.84
Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer (2006) 1.60
A Sod2 null mutation confers severely reduced adult life span in Drosophila. Genetics (2003) 1.58
Mitochondrial dysfunction in cancer. Front Oncol (2013) 1.57
Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol (2012) 1.56
Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med (2004) 1.51
Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res (2001) 1.48
UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci U S A (2014) 1.38
Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle (2011) 1.36
The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci (2016) 1.36
Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J (2007) 1.35
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med (2014) 1.27
Scavenging of extracellular H2O2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J Biol Chem (2000) 1.25
Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem (2011) 1.21
Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem (2001) 1.15
Phospholipase Cgamma1 is required for metastasis development and progression. Cancer Res (2008) 1.14
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control (2004) 1.13
Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res (2007) 1.11
Uncoupling protein-2 and cancer. Mitochondrion (2009) 1.10
Phospholipase signalling networks in cancer. Nat Rev Cancer (2012) 1.10
Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res (2015) 1.04
MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal (2013) 1.04
Reactive oxygen species signaling in cancer: comparison with aging. Aging Dis (2010) 1.02
MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun (2015) 0.99
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine. Biochim Biophys Acta (2012) 0.96
Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer (1994) 0.94
The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers (Basel) (2010) 0.93
Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger? J Cell Biochem (2014) 0.92
Manganese superoxide dismutase regulates a redox cycle within the cell cycle. Antioxid Redox Signal (2013) 0.90
Expression of phospholipases gamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol Carcinog (1995) 0.88
New aspects of mitochondrial Uncoupling Proteins (UCPs) and their roles in tumorigenesis. Int J Mol Sci (2011) 0.87
Role of uncoupling proteins in cancer. Cancers (Basel) (2010) 0.86
Overexpression of phospholipase C-gamma 1 in familial adenomatous polyposis. Cancer Res (1994) 0.84
Hydrogen peroxide induces the activation of the phospholipase C-gamma1 survival pathway in PC12 cells: protective role in apoptosis. Acta Biochim Biophys Sin (Shanghai) (2009) 0.81
Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors. Cancer Biomark (2013) 0.81
Altered distribution of phospholipase C-gamma 1 in benign hyperproliferative epidermal diseases. Cell Growth Differ (1992) 0.81
Modulation of MnSOD in Cancer:Epidemiological and Experimental Evidence. Toxicol Res (2010) 0.78
UCP2 knockout suppresses mouse skin carcinogenesis. Cancer Prev Res (Phila) (2015) 0.76
UCP2 knockout suppresses mouse skin carcinogenesis. Cancer Prev Res (Phila) (2015) 0.76
UCP2 overexpression enhanced glycolysis via activation of PFKFB2 during skin cell transformation. Oncotarget (2017) 0.75